Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
The company is engaged in a pharmaceutical company, develops and manufactures finished dosage formulations .
Strides Pharma Science Limited, is a listed public company incorporated on 28 June, 1990. It is classified as a public limited company and is located in , Maharashtra. It's authorized share capital is INR 218.37 cr and the total paid-up capital is INR 92.17 cr.
Read more
** All rupee values in INR crores.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
** Delivery timelines are on best-effort basis during working hours. Filings 3-4 hours. Reports 24-48 hours.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
| State | Type | Address |
|---|
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Managing Director | Arun Kumar Pillai
Shareholder
|
00084845 | 1 years |
| Director | Kausalya Santhanam
Shareholder
|
06999168 | 6 years |
| Director | Homi Rustam Khusrokhan | 00005085 | 9 years |
| Whole-time Director | Badree Komandur
Shareholder
|
07803242 | 9 years |
| Director | Mukta Malik Arora | 07225715 | 1 years |
| Director | Subir Chakraborty | 00130864 | 1 years |
| Whole-Time Director | Aditya Arun Kumar | 06999081 | 1 years |
| Additional Director | Ameet Pratapsinh Hariani | 00087866 | 2 years |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2024 available in Tofler Pro
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Axis Trustee Services Limited
No. of Loans: 1
Total Amount : 1,879.6 cr
ICICI Bank Limited
No. of Loans: 1
Total Amount : 200.0 cr
The Karnataka Bank Limited
No. of Loans: 1
Total Amount : 100.0 cr
HDFC Bank Limited
No. of Loans: 2
Total Amount : 0.9 cr
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| Alliance Pharmacy Pty Limited | Australia | - | - |
| Altima Innvovations Inc. | United States | - | - |
| Amneal Pharma Australia Pty Ltd | Australia | - | - |
| Amneal Pharmaceuticals Pty Ltd | Australia | - | - |
| Apollo Life sciences Holding Proprietary Limited | South Africa | - | - |
| Arrow Life Sciences (Malaysia) Sdn. Bhd | Malaysia | - | - |
| Arrow Pharma (Private) Limited | Sri Lanka | - | - |
| Arrow Pharma Life Inc. | Philippines | - | - |
| Arrow Pharma Pte Limited | Singapore | - | - |
| Arrow Pharma Pty Limited | Australia | - | - |
| Arrow Pharmaceuticals Pty Limited | Australia | - | - |
| ARROW REMEDIES PRIVATE LIMITED | Maharashtra | 2015 | ₹ 1.0 L |
| Beltapharm SpA | Italy | - | - |
| CHEMSYNTH LABORATORIES PRIVATE LIMITED | Telangana | 2009 | ₹ 6.9 Cr |
| FAGRIS MEDICA PRIVATE LIMIETED | Maharashtra | 2008 | ₹ 1.0 Cr |
| Generic Partners Holding Co. Pty Limited | Australia | - | - |
| Generic Partners Pty Limited | Australia | - | - |
| Generic Partners (Canada) Inc | Canada | - | - |
| Generic Partners (International) Pte Limited | Singapore | - | - |
| Generic Partners (M) SDN BHD | Malaysia | - | - |
| Generic Partners (NZ) Limited | New Zealand | - | - |
| Generic Partners (SA) Pty Limited | South Africa | - | - |
| Generic Partners UK Limited | United Kingdom | - | - |
| Pharmacy Alliance Group Holdings Pty Limited | Australia | - | - |
| Pharmacy Alliance Investments Pty Limited | Australia | - | - |
| Pharmacy Alliance Pty Limited | Australia | - | - |
| Shasun Foundation Trust | India | - | - |
| Shasun Pharma Solutions Inc. | United States | - | - |
| Shasun USA Inc.* | United States | - | - |
| Smarterpharm Pty Limited | Australia | - | - |
| SOLARA ACTIVE PHARMA SCIENCES LIMITED | India | - | - |
| Stabilis Pharma Inc. | United States | - | - |
| Stelis Biopharma (Malaysia) SDN. BHD. | Malaysia | - | - |
| Strides Africa Limited** | Virgin Islands, British | - | - |
| Strides Arcolab (Australia) Pty Limited | Australia | - | - |
| Strides Arcolab International Limited | United Kingdom | - | - |
| STRIDES CHEMICALS PRIVATE LIMITED | Maharashtra | 2003 | ₹ 79.7 Cr |
| Strides CIS Limited | Cyprus | - | - |
| STRIDES CONSUMER PRIVATE LIMITED | Maharashtra | 2017 | ₹ 72.7 Cr |
| STRIDES EMERGING MARKETS LIMITED | Karnataka | 2012 | ₹ 5.6 Cr |
| Strides Foundation Trust | India | - | - |
| ERIS HEALTHCARE PRIVATE LIMITED | India | - | - |
| Strides Life Sciences Limited | Nigeria | - | - |
| Strides Pharma (Cyprus) Limited | Cyprus | - | - |
| Strides Pharma (SA) Pty Limited | South Africa | - | - |
| Strides Pharma Global (UK) Limited (formerly Strides Pharma (UK) Limited) | United Kingdom | - | - |
| Strides Pharma Asia Pte Limited | Singapore | - | - |
| Strides Pharma Canada Inc | Canada | - | - |
| Strides Pharma Global Pte Limited | Singapore | - | - |
| Strides Pharma Inc. | United States | - | - |
| Strides Pharma International Limited | Cyprus | - | - |
| Strides Pharma Limited | Cyprus | - | - |
| Strides Pharma UK Limited (formerly Strides Shasun (UK) Limited) | United Kingdom | - | - |
| Strides Shasun Latina, SA de CV | Mexico | - | - |
| Strides Specialties (Holdings) Limited | Mauritius | - | - |
| Strides Vivimed Pte Ltd (formerly Vivimed Global Generics Pte Limited) | Singapore | - | - |
| SVADS Holdings SA | Switzerland | - | - |
| Trinity Pharma Proprietary Limited | South Africa | - | - |
| Universal Corporation Limited | Kenya | - | - |
| Solara Active Pharma Sciences Limited | India | - | - |
Read more
The incorporation date of STRIDES PHARMA SCIENCE LIMITED is 28 June, 1990
The authorized share capital of STRIDES PHARMA SCIENCE LIMITED is INR ₹ 218.4 Cr.
The paid-up capital of STRIDES PHARMA SCIENCE LIMITED is INR ₹ 92.2 Cr.
The registered address of STRIDES PHARMA SCIENCE LIMITED is Cyber One, Unit No. 902, Sector 30A, Plot No - 4 & 6, Vashi, Navi Mumbai, Sanpada, Thane, Thane, Maharashtra, India, 400703 - 400703
The CIN number of STRIDES PHARMA SCIENCE LIMITED is L24230MH1990PLC057062.